In this issue:
- Behavioural interventions to improve breast cancer screening outreach
- Denosumab in premenopausal women receiving oestradiol suppression
- Digital breast tomosynthesis for breast cancer diagnosis
- Race, ethnicity and risk of breast cancer subtypes
- Breast-conserving therapy vs postmastectomy breast reconstruction
- Chemotherapy-free treatment for HER2-positive early breast cancer
- Taxane + lobaplatin for TNBC
- Neoadjuvant olaparib with chemotherapy in TNBC
- Ribociclib-induced cutaneous adverse events
- ER-low HER2-negative breast cancer treated as TNBC
Please login below to download this issue (PDF)